IRCT2016070428786N1已完成1 期
Phase I Clinical Trial to Examine the Safety of Transplantation of Mesenchymal Stem Cells in New-onset Type 1 Diabetes Patients
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 8 years 至 40 years（—）
- 性别
- All
入选标准
- •Type 1 diabetes detection in less than 6 weeks; diabetes diagnosis according to American Diabetes Association; Presence of Antibodies against pancreatic beta cells; Both Sexes; Age: 8-40 years; Fasting C-peptide = 0.3 ng/ml
排除标准
- •Pregnancy or breastfeeding; Cancer; Any acute or severe disease (According to physicians diagnosis: such as cardiac, pulmonary, hepatic, kidney, mental,… diseases); Positive results for: HIV, HTLV, HBV, HCV, CMV; Immune deficient or hyper aesthesia; History of ketoacidosis
研究者
相似试验
尚未招募
不适用
A phase I clinical trial to study the safety of treatment with Tipifarnib (ZARNESTRA) combined with Bortezomib (VELCADE) in patients with myelodysplastic syndrome (MDS)myelodysplasiamyelodysplastic syndroom10018865NL-OMON30154niversitair Medisch Centrum Sint Radboud18
招募中
1 期
Phase I study for the efficacy and the safety of the perioperative urinastatin therapy in chest surgical patients with interstitial pneumonia.interstitial pneumonia, lung cancer, metastatic lung tumor, pneumothoraxJPRN-UMIN000003295Tokyo Women's Medical University of Medicine, Department of Surgery I30
已完成
1 期
A trial to test the safety of a herbal formulatioCTRI/2018/02/011689SK Biolabs100
已完成
1 期
A clinical trial to test the safety of a drugCTRI/2017/11/010540SK Biolabs100
已完成
1 期
A trial to test the safety of a drugCTRI/2017/12/010788SK Biolabs100